Prospects for the pharmaceuticals industry look good for 2013 thanks to an increase in drug approvals and growth in emerging markets. Lex's Stuart Kirk and Vincent Boland consider what's in store for the sector in the year ahead.
For more video content from the Financial Times, visit http://www.FT.com/video
